Is serum Osteopontin a predictor of carotid atherosclerosis severity among prevalent hemodialysis patients?
-
Published:2022-03
Issue:2
Volume:34
Page:75-85
-
ISSN:2529-9123
-
Container-title:Clínica e Investigación en Arteriosclerosis (English Edition)
-
language:en
-
Short-container-title:Clínica e Investigación en Arteriosclerosis (English Edition)
Author:
Behairy Maha A.ORCID,
Shawky Sahar,
Hamed Reham,
Bawady SomiaORCID,
Abdelsattar Hoda A.ORCID,
Bichari Walid
Reference34 articles.
1. US Renal Data System 2018 Annual Data Report. Chapter 8: Cardiovascular Disease in Patients with ESRD. Am J Kidney Dis 2019;73:S501–18. https://doi.org/10.1053/j.ajkd.2018.12.020.
2. Prevalence of subclinical atheromatous and associated risk factors in chronic kidney disease: the NEFRONA study;Betriu;Nephrol Dial Transplant,2014
3. Aortic ageing in ESRD: structural, hemodynamic, and mortality implications;London;J Am Soc Nephrol,2015
4. Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, et al. Kidney Disease: Improving Global Outcomes (KDIGO). Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2006;69:1945-53.
5. KDIGO 2017 clinical practice guidelines update for the diagnosis, evaluation, prevention, and treatment of chronic kidney Disease–Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2017;7:1–59.